4//SEC Filing
Smith Rachel 4
Accession 0001144204-18-000865
CIK 0001133869other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 5:04 PM ET
Size
6.1 KB
Accession
0001144204-18-000865
Insider Transaction Report
Form 4
Smith Rachel
VP of Research and Development
Transactions
- Award
Stock Option (right to buy)
2018-01-02+50,000→ 50,000 totalExercise: $1.57Exp: 2028-01-02→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]1/48th of the shares subject to the stock option award shall vest on the first day of each month, commencing February 1, 2018, until the stock option becomes fully vested and exercisable. However, the option is subject to early exercise and, therefore, all or any part of the option can be exercised at any time. If the reporting person elects to take advantage of the early exercise feature and purchase shares prior to the vesting of such shares, the shares will be deemed restricted stock and will be subject to a repurchase option in favor of the Registrant if the reporting person's service to the Registrant terminates prior to vesting.
Documents
Issuer
CAPRICOR THERAPEUTICS, INC.
CIK 0001133869
Entity typeother
Related Parties
1- filerCIK 0001593089
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 5:04 PM ET
- Size
- 6.1 KB